Literature DB >> 33693693

Go, cancer stem cell, go! CSCs overcome myelin inhibition to move within white matter pathways.

Daniel J Silver1,2, Justin D Lathia1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33693693      PMCID： PMC8453266          DOI： 10.1093/brain/awaa467

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   15.255


× No keyword cloud information.
  11 in total

1.  A CRITICAL REVIEW: THE PATHOLOGY OF CEREBRAL GLIOMAS.

Authors:  H J Scherer
Journal:  J Neurol Psychiatry       Date:  1940-04

Review 2.  Myelin-associated inhibitors in axonal growth after CNS injury.

Authors:  Cédric G Geoffroy; Binhai Zheng
Journal:  Curr Opin Neurobiol       Date:  2014-03-06       Impact factor: 6.627

3.  Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.

Authors:  Takashi Shingu; Allen L Ho; Liang Yuan; Xin Zhou; Congxin Dai; Siyuan Zheng; Qianghu Wang; Yi Zhong; Qing Chang; James W Horner; Brandon D Liebelt; Yu Yao; Baoli Hu; Yiwen Chen; Gregory N Fuller; Roeland G W Verhaak; Amy B Heimberger; Jian Hu
Journal:  Nat Genet       Date:  2016-11-14       Impact factor: 38.330

4.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

5.  Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma.

Authors:  Jun-Hee Hong; Sangjo Kang; Jason K Sa; Gunwoo Park; Young Taek Oh; Tae Hoon Kim; Jinlong Yin; Sung Soo Kim; Fulvio D'Angelo; Harim Koo; Yeonhee You; Saewhan Park; Hyung Joon Kwon; Chan Il Kim; Haseo Ryu; Weiwei Lin; Eun Jung Park; Youn-Jae Kim; Myung-Jin Park; Hyunggee Kim; Mi-Suk Kim; Seok Chung; Chul-Kee Park; Sung-Hye Park; Yun Hee Kang; Jong Heon Kim; Hideyuki Saya; Ichiro Nakano; Ho-Shin Gwak; Heon Yoo; Jeongwu Lee; Eun-Mi Hur; Bingyang Shi; Do-Hyun Nam; Antonio Iavarone; Seung-Hoon Lee; Jong Bae Park
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

6.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

7.  Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment.

Authors:  Daniel J Silver; Florian A Siebzehnrubl; Michela J Schildts; Anthony T Yachnis; George M Smith; Amy A Smith; Bjorn Scheffler; Brent A Reynolds; Jerry Silver; Dennis A Steindler
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

8.  Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.

Authors:  Michael R Drumm; Karan S Dixit; Sean Grimm; Priya Kumthekar; Rimas V Lukas; Jeffrey J Raizer; Roger Stupp; Milan G Chheda; Kwok-Ling Kam; Matthew McCord; Sean Sachdev; Timothy Kruser; Alicia Steffens; Rodrigo Javier; Kathleen McCortney; Craig Horbinski
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

Review 9.  Cancer stem cells in glioblastoma.

Authors:  Justin D Lathia; Stephen C Mack; Erin E Mulkearns-Hubert; Claudia L L Valentim; Jeremy N Rich
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

10.  The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.

Authors:  Florian A Siebzehnrubl; Daniel J Silver; Bugra Tugertimur; Loic P Deleyrolle; Dorit Siebzehnrubl; Matthew R Sarkisian; Kelly G Devers; Antony T Yachnis; Marius D Kupper; Daniel Neal; Nancy H Nabilsi; Michael P Kladde; Oleg Suslov; Simone Brabletz; Thomas Brabletz; Brent A Reynolds; Dennis A Steindler
Journal:  EMBO Mol Med       Date:  2013-07-01       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.